Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 3/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 8/20 | 0.32 |
| ▸ | CA2 | P00918 | 8/20 | 0.32 |
| ▸ | CA9 | Q16790 | 7/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.32 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA7 | P43166 | 3/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.32 |
| ▸ | CA3 | P07451 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23355248 | 1.00 | GBA1 (0.38) | GBA1EPHX2RECQLGLAHPGD | |
| SCHEMBL23355250 | 1.00 | GBA1 (0.38) | GBA1EPHX2RECQLGLAHPGD | |
| SCHEMBL23355257 | 1.00 | GBA1 (0.38) | GBA1EPHX2RECQLGLAHPGD | |
| SCHEMBL23355234 | 1.00 | GBA1 (0.38) | GBA1EPHX2RECQLGLAHPGD | |
| SCHEMBL23355254 | 1.00 | GBA1 (0.38) | GBA1EPHX2RECQLGLAHPGD | |
| SCHEMBL23355238 | 1.00 | GBA1 (0.38) | GBA1EPHX2RECQLGLAHPGD | |
| SCHEMBL23355225 | 1.00 | GBA1 (0.38) | GBA1EPHX2RECQLGLAHPGD | |
| SCHEMBL23355255 | 1.00 | GBA1 (0.38) | GBA1EPHX2RECQLGLAHPGD | |
| SCHEMBL23355235 | 1.00 | GBA1 (0.38) | GBA1EPHX2RECQLGLAHPGD | |
| SCHEMBL23355246 | 1.00 | GBA1 (0.38) | GBA1EPHX2RECQLGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3820846-B1 | COMPOSITION FOR INHIBITING MONOMER POLYMERIZATION COMPRISING A NITROXIDE INHIBITOR, A QUINONE METHIDE RETARDER AND AN AMINE STABILIZER | ECOLAB USA INC (US) | 2024-01-03 | — | — | EP | claimed |
| EP-3820846-A1 | COMPOSITION FOR INHIBITING MONOMER POLYMERIZATION COMPRISING A NITROXIDE INHIBITOR, A QUINONE METHIDE RETARDER AND AN AMINE STABILIZER | Ecolab USA, Inc. (US) | 2021-05-19 | — | — | EP | claimed |
| CN-112533902-A | Compositions comprising nitroxide inhibitors, quinone methide blockers and amine stabilizers to inhibit polymerization of monomers | 埃科莱布美国股份有限公司 | 2021-03-19 | — | — | CN | claimed |
| EP-3820846-A1 | COMPOSITION FOR INHIBITING MONOMER POLYMERIZATION COMPRISING A NITROXIDE INHIBITOR, A QUINONE METHIDE RETARDER AND AN AMINE STABILIZER | Ecolab USA, Inc. (US) | 2021-05-19 | — | — | EP | disclosed |
| CN-112533902-A | Compositions comprising nitroxide inhibitors, quinone methide blockers and amine stabilizers to inhibit polymerization of monomers | 埃科莱布美国股份有限公司 | 2021-03-19 | — | — | CN | disclosed |
| EP-1311472-B1 | METHOD FOR PREPARING ALKOXYAMINES FROM NITROXIDES | ATOFINA (FR) | 2004-10-20 | — | — | EP | disclosed |
| US-6700007-B2 | IN A BIPHASIC MEDIUM, BY MIXING AN IONIC LIQUID SUCH AS AN ALKYLIMIDAZOLIUM HALIDE, AN ORGANIC SOLVENT, A TRANSITION METAL SALT, A METAL LIGAND, A HALOHYDROCARBON AND A NITROXIDE | ATOFINA (FR) | 2004-03-02 | — | — | US | disclosed |
| EP-1311472-A2 | METHOD FOR PREPARING ALKOXYAMINES FROM NITROXIDES | Atofina (FR) | 2003-05-21 | — | — | EP | disclosed |
| US-20030050507-A1 | Method for prepararing alkoxyamines from nitroxides | ATOFINA (FR) | 2003-03-13 | — | — | US | disclosed |
| WO-2002012149-A2 | METHOD FOR PREPARING ALKOXYAMINES FROM NITROXIDES | ATOFINA (FR) | 2002-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030050507-A1 | Method for prepararing alkoxyamines from nitroxides | ZYX, ZFX, PNMT | GBA1 3320/4885EPHX2 405/4885RECQL 3407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.